Adjuvant and neoadjuvant therapies are treatments delivered before or after the primary treatment—in most cases, surgery—to help increase its chance of success and decrease the risk of cancer recurrence.
- Neoadjuvant therapy is given to a patient before surgery to help shrink a tumor or stop disease spread to optimize the main treatment’s success rate and, if possible, make it less invasive.
- Adjuvant therapy is delivered after surgery to kill any remaining cancer cells in the area and lower the risk of the cancer coming back.
https://www.cancercenter.com/community/blog/2024/01/neoadjuvant-vs-adjuvant
Lynch Syndrome Ireland 